Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in Harvard Catalyst Profiles by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 2 | 4 | 6 |
2001 | 13 | 17 | 30 |
2002 | 18 | 22 | 40 |
2003 | 28 | 32 | 60 |
2004 | 30 | 18 | 48 |
2005 | 34 | 28 | 62 |
2006 | 28 | 27 | 55 |
2007 | 23 | 43 | 66 |
2008 | 25 | 29 | 54 |
2009 | 33 | 28 | 61 |
2010 | 41 | 28 | 69 |
2011 | 33 | 29 | 62 |
2012 | 43 | 31 | 74 |
2013 | 44 | 19 | 63 |
2014 | 36 | 22 | 58 |
2015 | 42 | 23 | 65 |
2016 | 23 | 27 | 50 |
2017 | 19 | 18 | 37 |
2018 | 27 | 23 | 50 |
2019 | 19 | 31 | 50 |
2020 | 10 | 26 | 36 |
2021 | 4 | 18 | 22 |
2022 | 3 | 4 | 7 |
2023 | 1 | 4 | 5 |
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.
-
Impact of antiretroviral therapy intensification with C-C motif chemokine receptor 5 antagonist maraviroc on HIV-associated neurocognitive impairment. AIDS. 2023 11 01; 37(13):1987-1995.
-
Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV. Antivir Ther. 2023 06; 28(3):13596535231182505.
-
Trajectories of Antiretroviral Therapy Adherence and Virologic Failure in Women With HIV in the United States. J Acquir Immune Defic Syndr. 2023 06 01; 93(2):162-170.
-
Infants Receiving Very Early Antiretroviral Therapy Have High CD4 Counts in the First Year of Life. Clin Infect Dis. 2023 02 08; 76(3):e744-e747.
-
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance. AIDS Res Ther. 2023 01 05; 20(1):3.
-
"I am alive because of her": factors affecting adherence to combination antiretroviral therapy among people living with HIV in KwaZulu-Natal, South Africa. BMC Infect Dis. 2022 Aug 08; 22(1):680.
-
Predictive value of CD8+ T cell and CD4/CD8 ratio at two years of successful ART in the risk of AIDS and non-AIDS events. EBioMedicine. 2022 Jun; 80:104072.
-
Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception. J Infect Dis. 2022 04 01; 225(7):1162-1167.
-
Aortic Valve Repair Using HAART 300 Geometric Annuloplasty Ring: A Review and Echocardiographic Case Series. J Cardiothorac Vasc Anesth. 2022 11; 36(11):3990-3998.
-
HIV and Aging in the Era of ART and COVID-19: Symposium Overview. J Acquir Immune Defic Syndr. 2022 02 01; 89(Suppl 1):S3-S9.